HIV Controllers: Implications for HIV Cure/Remission
Bruce D. Walker, MD
Director, Ragon Institute of MGH, MIT and Harvard
Director, Harvard University Center for AIDS Research
Phillip T and Susan M Ragon Professor of Medicine, Harvard Medical School Professor of the Practice, Institute for Medical Engineering & Science, MIT
Investigator, Howard Hughes Medical Institute
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2017. All rights reserved.
Bruce Walker is the Director of the Ragon Institute of MGH, MIT and
Harvard, a Professor of Medicine at Harvard Medical School, a Professor of
Practice at MIT and a Howard Hughes Medical Institute Investigator. In
addition to his clinical duties as a board certified Infectious Disease
specialist, his research focuses on cellular immune responses in chronic
viral infections, with a particular focus on HIV. He leads an international
translational clinical and basic science research effort to understand how
some rare people who are infected with HIV, but have never been treated,
can fight the virus with their immune system. Dr. Walker is also an Adjunct
Professor at the Nelson Mandela School of Medicine in Durban, South
Africa. There he collaborates with the Doris Duke Medical Research
Institute at the University of KwaZulu-Natal and serves as a Principal
Investigator in the HIV Pathogenesis Program, an initiative to study the
evolution of the HIV and the immune responses effective in controlling this
virus, as well as to contribute to training African scientists.
At the completion of this educational session, learners will:
- Understand the immunologic and host genetic basis for durable control.
- Appreciate the current barriers to long-term functional cure.
- Understand prospects for reactivation and immunologic elimination of the latent virus reservoir.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
